Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Mellion

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Rhode Island Medical Journal (2013)|August 8, 2013
Impact of preventive medications in migraine patients at Rhode Island HospitalDeena Kuruvilla, Michelle Mellion
The International Journal of Neuroscience|December 6, 2014
Jaw clonus frequency does not support hypothesis of peripheral mechanism of self-re-excitationJoseph H Friedman, Michelle Mellion
Muscle & Nerve|February 16, 2011
Alcohol-related peripheral neuropathy: nutritional, toxic, or both?Michelle Mellion, James M Gilchrist, Suzanne de la Monte
Neurology International|April 24, 2023
Post-Polio Syndrome RevisitedMichael Punsoni, Nelli S Lakis, Michelle Mellion, et al.
Nutrients|September 28, 2012
Experimental alcohol-related peripheral neuropathy: role of insulin/IGF resistanceVan Anh Nguyen, Tran Le, Ming Tong, et al.
Neuromuscular Disorders : NMD|June 24, 2026
A portrait of facioscapulohumeral muscular dystrophy through history: past milestones and future challenges on the road to understanding and treatmentAnna Greco, George W Padberg, Kees van de Graaf, et al.
The Lancet. Neurology|July 10, 2019
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trialDiego Cadavid, Michelle Mellion, Raymond Hupperts, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Rhode Island Medical Journal (2013)|August 8, 2013
Impact of preventive medications in migraine patients at Rhode Island HospitalDeena Kuruvilla, Michelle Mellion
The International Journal of Neuroscience|December 6, 2014
Jaw clonus frequency does not support hypothesis of peripheral mechanism of self-re-excitationJoseph H Friedman, Michelle Mellion
Muscle & Nerve|February 16, 2011
Alcohol-related peripheral neuropathy: nutritional, toxic, or both?Michelle Mellion, James M Gilchrist, Suzanne de la Monte
Neurology International|April 24, 2023
Post-Polio Syndrome RevisitedMichael Punsoni, Nelli S Lakis, Michelle Mellion, et al.
Nutrients|September 28, 2012
Experimental alcohol-related peripheral neuropathy: role of insulin/IGF resistanceVan Anh Nguyen, Tran Le, Ming Tong, et al.
Neuromuscular Disorders : NMD|June 24, 2026
A portrait of facioscapulohumeral muscular dystrophy through history: past milestones and future challenges on the road to understanding and treatmentAnna Greco, George W Padberg, Kees van de Graaf, et al.
The Lancet. Neurology|July 10, 2019
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trialDiego Cadavid, Michelle Mellion, Raymond Hupperts, et al.
Pageof 1